[2-Oxo-2-[(9R,11S,14S,16R,17R)-6,6,9-Trifluoro-11,16-Dihydroxy-10,13,17-Trimethyl-3-Oxo-8,11,12,14,15,16-Hexahydro-7H-Cyclopenta[a]P henanthren-17-Yl]Ethyl] Acetate
CAS: 35135-67-2
Ref. 3D-FO104210
Tamaño no definido | A consultar |
Información del producto
- (11b,16a)-21-(Acetyloxy)-6,6,9-trifluoro-11,17-dihydroxy-16-methyl-pregna-1,4-diene-3,20-dione
- (11b,16a)-6,6,9-Trifluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl Acetate
- 35135-67-2
- Cormethasone acetate
- Rs 3694R
The present invention is a pharmaceutical preparation comprising 2-oxo-2-[(9R,11S,14S,16R,17R)-6,6,9-trifluoro-11,16-dihydroxy-10,13,17-trimethyl-3-oxo-8,11,12,14,15,16-hexahydrocyclopenta[a]ph enanthrene-17-yl]ethanol acetate. The compound has been shown to be effective in the treatment of inflammatory diseases and cardiac hypertrophy. It also has a diagnostic use for the detection of autoimmune diseases and cavity.
Propiedades químicas
Consulta técnica sobre: 3D-FO104210 [2-Oxo-2-[(9R,11S,14S,16R,17R)-6,6,9-Trifluoro-11,16-Dihydroxy-10,13,17-Trimethyl-3-Oxo-8,11,12,14,15,16-Hexahydro-7H-Cyclopenta[a]P henanthren-17-Yl]Ethyl] Acetate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.